M. Guo et Jj. Reiners, Phorbol ester-induced production of cytostatic factors by normal and oncogenic Ha-ras-transformed human breast cell lines, CARCINOGENE, 21(7), 2000, pp. 1303-1312
The effects of 12-O-tetradecanoylphorbol-13-acetate (TPA) on cell cycle pro
gression were examined in the human breast cell line MCF10A-Neo and a deriv
ative fine which expresses a Ha-ras oncogene (MCF10A-NeoT cells). Exposure
of MCF10A-Neo cultures to TPA induced a G(1) arrest that lasted similar to
16-24 h (IC50 similar to 0.5 nM), TPA-treated cultures produced a cytostati
c conditioned medium. Cytostatic activity was detectable within 1 h of TPA
treatment, peaked 3-7 h later and disappeared between 16 and 24 h posttreat
ment, However, cytostatic conditioned medium could be quickly regenerated b
y re-feeding previously treated cultures with new medium. Removal of latent
transforming growth factor beta (TGF beta) from the culture medium, supple
menting the culture medium with anti-TGF beta or soluble TGF beta(II) recep
tor, or pre-absorption of conditioned medium with anti-TGF beta all reduced
the cytostatic effects of TPA or conditioned medium on MCF10A-Neo prolifer
ation by similar to 50%. Go-treatment with the serine protease inhibitors a
protinin or plasminogen activator inhibitor-1 also suppressed the cytostati
c activity of TPA similar to 50%, Conditioned medium isolated from TPA-trea
ted MCF10A-Neo cultures was transiently cytostatic to MGF10A-NeoT cells. Th
e proliferation of MCF10A-NeoT cultures, in contrast to MCF10A-Neo cells, w
as suppressed at least 72 h following TPA exposure. Conditioned medium isol
ated from TPA-treated MCF10A-NeoT cultures also suppressed MCF10A-NeoT prol
iferation for similar to 72 h, but suppressed MCF10A-Neo proliferation for
<24 h, These studies suggest that TPA quickly activates proteolytic process
es in MCF10A-Neo cells leading to the activation of latent TGF beta supplie
d by the serum in the culture medium. TPA also stimulates the production of
an additional cytostatic factor(s) which signals via a mechanism not invol
ving the TGF beta(II) receptor. Lastly, expression of an activated Ha-ras o
ncogene alters both the types of cytostatic factors produced following TPA
treatment and responsiveness to these factors.